New Biomarker Algorithm for Noninvasive Detection of Esophageal Cancer
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Unknown Origin & Other Cancer Types |
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Sepsis |
Inflammatix’s test system provides accurate infection likelihood and illness severity assessments for sepsis and acute infections.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Prostate |
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read MorePosted by Andy Lundin | Jan 17, 2025 | Molecular Diagnostics |
Researchers demonstrated the potential of mcfDNA testing to identify pathogens in pediatric head and neck infections.
Read MorePosted by Andy Lundin | Jan 17, 2025 | Controls |
Verichem Labs’ biosynthetic clinical reference materials are for the calibration verification and quality control of urine chemistry assays.
Read More